A second look at the pT1 G3 bladder tumour

Clinical Oncology

Volumn 17, Issue 7, 2005, Pages 498-502

  Harland, S Jonathan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL TRIAL; CYSTECTOMY; DEATH; HIGH RISK PATIENT; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SYSTEMATIC REVIEW; TRANSURETHRAL RESECTION; TUMOR VOLUME;

BCG VACCINE; CARCINOMA IN SITU; CLINICAL TRIALS; COMBINED MODALITY THERAPY; CYSTECTOMY; DISEASE PROGRESSION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 25144434225     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2005.07.005     Document Type: Article

References (33)

1. B.R. Birch S.J. Harland The pT1 G3 bladder tumour Br J Urol 64 1989 109-116
2. H. Wolf K. Hojgaard Prognostic factors in local surgical treatment of invasive bladder cancer with special reference to the presence of urothelial dysplasia Cancer 51 1983 1710-1715
3. G. Jakse W. Loidl G. Seeber F. Hofstadter Stage T1, grade 3 transitional cell carcinoma of the bladder: An unfavourable tumour? J Urol 137 1987 39-43
4. M. Stockle P. Alken U. Engelmann G.H. Jacobi H. Ridmiller R. Hohenfellner Radical cystectomy - often too late? Eur Urol 13 1987 361-367
5. C.L. Amling J.B. Thrasher H.A. Frazier R.K. Dodge J.E. Roberton D.F. Paulson Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder J Urol 151 1994 31-35
6. J.A. Freeman D. Esrig J.P. Stein et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction Cancer 76 1995 833-839
7. S.C. Dutta J.A. Smith Jr. S.B. Shappell C.S. Coffey S.S. Chang M.S. Cookson Clinical understaging of high risk non-muscle invasive urothelial carcinoma treated with radical cystectomy J Urol 166 2001 490-493
8. M.D. Shelley H. Kynaston J. Court et al. A systematic review of intravesical bacillus calmette-guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer BJU Int 88 2001 209-216
9. D.L. Lamm BCG in perspective: Advances in the treatment of superficial bladder cancer Eur Urol 27 suppl 1 1995 2-8
10. M.D. Shelley T.J. Wilt J. Court B. Coles H. Kynaston M.D. Mason Intravesical bacillus calmette-guerin is superior to mitomycin-C in reducing tumour recurrence in high risk superficial bladder cancer: A meta-analysis of randomised trials BJU Int 93 2004 485-490
11. R.J. Sylvester A.P. van der Meijden D.L. Lamm Intravesical bacillus calmette-guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomised clinical trials J Urol 168 2002 964-970
12. R.A. Badalament H.W. Herr G.Y. Wong et al. A prospective randomised trial of maintenance vs non-maintenance intravesical bacillus calmette-guerin therapy of superficial bladder cancer J Clin Oncol 5 1986 441-449
13. D.L. Lamm B.A. Blumenstein J.D. Crissman et al. Maintenance bacillus calmette-guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomised South West Oncology Group study J Urol 163 2000 1124-1129
14. J. Palou P. Laguna F. Millan-Rodriguez R.R. Hall J. Salvador-Bayarri J. Vicente-Rodiguez Controlled group and maintenance treatment with bacillus calmette-guerin for carcinoma in situ and/or high grade bladder tumours J Urol 165 2001 1488-1491
15. O. Shahin G.N. Thalmann C. Rentsch L. Mazzucchelli U.E. Studer A retrospective analysis of 153 patients treated with or without intravesical bacillus calmette-guerin for primary stage T1 grade 3 bladder cancer: Recurrence, progression and survival J Urol 169 2003 96-100
16. I.S. Sawczuk C.A. Olsson R. de Vere White The limited usefulness of external beam radiotherapy in the control of superficial bladder cancer Br J Urol 61 1988 330-332
17. P.R. Riddle G.D. Chisholm P.A. Trott R.C. Pugh Flat carcinoma in situ of bladder Br J Urol 47 1975 829-833
18. W.F. Whitmore G.R. Prout Discouraging results for high dose external beam radiation therapy in low stage (0 and A) bladder cancer J Urol 127 1982 902-905
19. B.J. Jenkins H.R. England C.G. Fowler et al. Chemotherapy for carcinoma in situ of bladder Br J Urol 61 1988 326-329
20. P.M. Quilty W. Duncan Treatment of superficial (T1) tumours of the bladder by radical radiotherapy Br J Urol 58 1986 147-152
21. T.H. Lynch B. Waymont J.A. Dunne D.M. Wallace Urologists' attitudes to the management of bladder cancer Br J Urol 70 1992 522-555
22. G.N. Thalmann R. Markwalder O. Shahin F.C. Burkhard W.W. Hochreiter U.E. Studer Primary T1 G3 bladder cancer: Organ-preserving approach or immediate cystectomy? J Urol 172 2004 70-75
23. P.F. Mulders W.J. Hoekstra R.P. Heybroek et al. Prognosis and treatment of T1 G3 bladder tumours. A prognostic factor analysis of 121 patients. Dutch South East Bladder Cancer Study Group Eur J Cancer 30A 1994 914-917
24. V. Pansadoro P. Miliozzi F. de Paula P. Scarpone A. Pansadoro C.N. Sternberg Long-term follow up of G3 T1 transitional cell carcinoma of the bladder treated with intravesical bacille calmette-guerin: 18 year experience Urology 59 2002 227-231
25. T. Lebret F. Gaudez J.M. Herve P. Barre P.M. Lugagne H. Botto Low dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success Eur Urol 34 1998 67-72
26. R. Hurle A. Losa A. Manzetti A. Lembo Intravesical bacille calmette-guerin in stage T1 G3 bladder cancer therapy: A 7 year follow up Urology 54 1999 258-263
27. G. Smith R.A. Elton G.D. Chisholm J.E. Newsam T.B. Hargreave Superficial bladder cancer: Intravesical therapy and tumour progression to muscle invasional metastases Br J Urol 58 1986 659-663
28. R.B. Bracken M.W. McDonald D.E. Johnson Cystectomy for superficial bladder cancer Urology 18 1981 459-463
29. J. Baniel D. Grauss D. Engelstein A. Sella Intravesical bacillus calmette-guerin treatment for stage T1 grade 3 transitional cell carcinoma of the bladder Urology 52 1998 785-789
30. M. Brake H. Loertzer R. Horsch H. Keller Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus calmette-guerin J Urol 163 2000 1697-1701
31. J.J. Patard S. Moudouni F. Saint et al. Tumour progression and survival in patients with T1 G3 bladder tumours: Multicentric retrospective study comparing 94 patients treated during 17 years Urology 58 2001 551-556
32. J.N. Kulkarni R. Gupta Recurrence and progression in stage T1 G3 bladder tumour with intravesical bacille calmette-guerin (Danish 1331 strain) BJU Int 90 2002 554-557
33. M. Peyromaure M. Zerbib T1 G3 transitional cell carcinoma of the bladder: Recurrence, progression and survival BJU Int 93 2004 60-63